New study tests Under-the-Tongue tablet to ward off Kids' winter colds
Prevention
Recruiting now
This study tests whether PMBL® sublingual tablets can reduce the number of respiratory infections (like colds) in children aged 3 to 12 who are prone to getting sick. Half the children will receive the active tablet, and half will receive a placebo (inactive tablet) for 3 months,…
Phase: PHASE4 • Sponsor: Lallemand Pharma AG • Aim: Prevention
Last updated Jul 10, 2026 00:00 UTC